Summary: Marine shipping is a viable option for pharmaceuticals – even for temperature-sensitive, high value products. But this new, cost-effective option calls for closer scrutiny of temperature controls throughout the journey and – importantly – the use of monitoring and logging technologies to document proper handling.

This white paper discusses:

• The shift towards marine shipping for pharmaceuticals
• The expansion of the pharmaceutical cold chain (including CRT)
• The role of intermodal shipping
• Pros and cons of marine transportation
• Advances in reefers and monitors
• Risk assessments for marine shipping
• Data logging technologies to reduce risks

Who Should Read This:

• Pharmaceutical logistics managers
• Senior life science executives responsible for logistics and the supply chain
• Carriers
• Third party logistics sources (3PLs) working with life science companies
• Pharmaceutical distributors